OGN Organon & Co. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Organon & (OGN) Stock: Buy, Sell, or Hold?

$13.89
+0.00 (+0.00%) ▲
5d: +0.43% 30d: +0.87% 90d: +1.24%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (22%)
Quality Score
46/100
Position
EXTENDED
30-Day Fair Range
$13.74 – $13.84
Position: EXTENDED
Forward P/E & Valuation
3.8x STRETCHED
vs 3.0x historical avg
Wall Street Target
$10.33
-25.6% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$13.76 / $13.89
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: OGN shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When OGN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$14.03
Based on 5.1% avg growth
INTRINSIC VALUE TODAY
$8.71
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: OGN is currently trading at $13.89, which is considered extended relative to its 30-day fair value range of $13.74 to $13.84. From a valuation perspective, the stock is trading at a premium (Forward PE: 3.8) compared to its historical average (3.0). At these levels, the market is pricing in 8.5% annual earnings growth.

Technical Outlook: Technically, OGN is in a strong uptrend. The price is currently testing key support at $13.76. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: OGN scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $10.33. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $13.74 - $13.84
Company Quality Score 46/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 22.4%

Trading Range & Key Levels

30-Day Trading Range $13.74 - $13.84
Current vs Trading Range EXTENDED
Support Level $13.76
Resistance Level $13.89
Current Trend Strong Uptrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding OGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (34/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading 25.6% above Wall St target ($10.33)
  • BULLISH: Expecting earnings turnaround to 8.5% growth with -1.7% revenue growth
  • WARNING: Composite score 46/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) 3.81
Wall Street Target $10.33 (-25.6%)
Revenue Growth (YoY) -1.7%
Earnings Growth (YoY) -1.6%
Profit Margin 3.5%
Valuation Premium vs History +8.5% premium
PE vs Historical 3.8 vs 3.0 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +8.5% (market-implied from PE analysis)
1-Year Target $15.07 (+9%)
2-Year Target $16.35 (+18%)
3-Year Target $17.74 (+28%)
3-Yr Target (if PE normalizes) (PE: 4→3) PE COMPRESSION $13.98 (+1%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 19.9, Growth: 6.2%) $86.66 (+524%)
Base: (SPY PE: 3.8, Growth: 6.2%) $16.62 (+20%)
Bear: (PE: 3.0, Growth: 6.2%) $13.09 (-6%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 17.81 | Current EPS (TTM): $0.78
Bull Case $30.56 (+120%)
Analyst growth 100.0%, PE expands to 19.6
Base Case $27.78 (+100%)
Market implied 100.0%, PE stable at 17.8
Bear Case $9.45 (-32%)
Severe decline -20.0%, PE contracts to 15.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share OGN Analysis

Share this live OGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (OGN)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
May 3, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish StockTwits message suggests a 40% gain in $OGN since being alerted, with further potential upside.
Key Retail Themes: Bullish outlook on $OGN
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 9:28 AM ET
Data refreshes hourly during market hours. Next update: 10:28 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for OGN.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - General Stocks

Top-rated stocks in Drug Manufacturers - General by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ABBV
AbbVie Inc
STRONG BUY
29 analysts
$306 48 HOLD
BIIB
Biogen Inc
BUY
36 analysts
$266 43 HOLD
LLY
Eli Lilly and Company
STRONG BUY
31 analysts
$1453 27 SELL
MRK
Merck & Company Inc
BUY
28 analysts
$162 50 HOLD
GILD
Gilead Sciences Inc
STRONG BUY
28 analysts
$175 37 SELL

Advanced OGN Option Strategies

Professional options setups generated by AI based on today's OGN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive OGN Research Pages
OGN Technical Chart OGN Price Prediction OGN Intrinsic Value DCF OGN Earnings Date OGN Investment Advisor OGN Fair Price Analyzer OGN Options Chain OGN Options Advisor OGN Options Analysis OGN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals